NEUROCRINE BIOSCIENCES INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Neurocrine Biosciences Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Neurocrine Biosciences Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 101M shares, a 3.38% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 101M +3.3M +3.38% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 101M +3.1M +3.18% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 98.7M +2.2M +2.28% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 98.2M +2.1M +2.19% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 97.6M +2M +2.09% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 97.5M +2M +2.09% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 96.5M +1.6M +1.69% Dec 31, 2022 10-K 2024-02-09
Q3 2022 96.1M +1.3M +1.37% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 95.6M +1M +1.06% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 95.5M +1M +1.06% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 94.9M +1.4M +1.5% Dec 31, 2021 10-K 2023-02-09
Q3 2021 94.8M +1.4M +1.5% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 94.6M +1.4M +1.5% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 94.5M +1.7M +1.83% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 93.5M +1.2M +1.3% Dec 31, 2020 10-K 2022-02-11
Q3 2020 93.4M +1.32M +1.43% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 93.2M +1.66M +1.82% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 92.8M +1.52M +1.66% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 92.3M +1.5M +1.66% Dec 31, 2019 10-K 2021-02-05
Q3 2019 92.1M +1.41M +1.55% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 91.5M +1.13M +1.25% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 91.3M +1.4M +1.56% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 90.8M +2M +2.26% Dec 31, 2018 10-K 2020-02-07
Q3 2018 90.7M +2.21M +2.5% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 90.4M +2.19M +2.48% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 89.9M +2.36M +2.7% Mar 31, 2018 10-Q 2018-04-30
Q4 2017 88.8M +1.91M +2.2% Dec 31, 2017 10-K 2019-02-08
Q3 2017 88.5M +1.6M +1.84% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 88.2M +1.47M +1.69% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 87.5M +947K +1.09% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 86.9M +621K +0.72% Dec 31, 2016 10-K 2018-02-13
Q3 2016 86.9M +982K +1.14% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 86.8M +1M +1.17% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 86.6M +1.2M +1.41% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 86.3M +9.8M +12.8% Dec 31, 2015 10-K 2017-02-14
Q3 2015 85.9M +9.89M +13% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 85.8M +9.83M +13% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 85.4M +9.51M +12.5% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 76.5M +9.11M +13.5% Dec 31, 2014 10-K 2016-02-11
Q3 2014 76M +8.65M +12.8% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 75.9M +8.92M +13.3% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 75.9M +9.15M +13.7% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 67.4M +904K +1.36% Dec 31, 2013 10-K 2015-02-09
Q3 2013 67.3M +962K +1.45% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 67M +678K +1.02% Jun 30, 2013 10-Q 2013-07-26
Q1 2013 66.7M +406K +0.61% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 66.4M +11.2M +20.2% Dec 31, 2012 10-K 2014-02-11
Q3 2012 66.4M +11.1M +20.1% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 66.3M +11.1M +20.1% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 66.3M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 55.3M +381K +0.69% Dec 31, 2011 10-K 2013-02-08
Q3 2011 55.3M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 55.2M Jun 30, 2011 10-Q 2011-07-29
Q4 2010 54.9M Dec 31, 2010 10-K 2012-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.